We are live on ! Find out more
MDVX

Medovex Corp. Common Stock
MDVX

Delisted

MDVX was delisted on the 15th of November, 2017.

Back to rankings

9 hedge funds and large institutions have $152K invested in Medovex Corp. Common Stock in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

50% more funds holding

Funds holding: 6 → 9 (+3)

0.18% more ownership

Funds ownership: 0.76% → 0.94% (+0.18%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

13% less capital invested

Capital invested by funds: $174K → $152K (-$22K)

Holders
9
Holders Change
+3
Holders Change %
+50%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$34.2K
2
Fisher Asset Management
Fisher Asset Management
Washington
+$32.1K
3
BW
Bison Wealth
Georgia
+$11.7K
4
UBS Group
UBS Group
Switzerland
+$7.97K
5
Deutsche Bank
Deutsche Bank
Germany
+$3.67K

Top Sellers

Rank Fund Capital Flow
1
FPF
FNY Partners Fund
New York
-$12K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$6.88K

MDVX Hedge Fund Activity: Q2 2017 in Review

9 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Medovex Corp. Common Stock (MDVX) for Q2 2017, worth a combined $152K — down 13% from $174K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new MDVX positions and 2 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $34.2K. The largest seller was FNY Partners Fund, exiting entirely with an estimated $12K sold.

  • 9 institutional investors held Medovex Corp. Common Stock (MDVX) as of Q2 2017, up from 6 in Q1 2017.
  • Funds reported $152K of Medovex Corp. Common Stock stock for Q2 2017, down 13% quarter-over-quarter.
  • 5 funds opened new Medovex Corp. Common Stock positions in Q2 2017 and 2 closed out, a net change of +3 holders.
  • The largest Medovex Corp. Common Stock buyer in Q2 2017 was Citadel Advisors, an estimated $34.2K added.
  • The largest Medovex Corp. Common Stock seller in Q2 2017 was FNY Partners Fund, an estimated $12K sold.

Based on aggregated 13F filings for Q2 2017.